Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5092578
Max Phase: Preclinical
Molecular Formula: C45H74N12O10
Molecular Weight: 943.16
Molecule Type: Unknown
Associated Items:
ID: ALA5092578
Max Phase: Preclinical
Molecular Formula: C45H74N12O10
Molecular Weight: 943.16
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C45H74N12O10/c1-7-15-31(39(61)50-28(5)38(60)55-33(44(66)67)19-13-22-49-45(47)48)53-37(59)27(4)51-40(62)34(24-26(2)3)56-42(64)36-20-14-23-57(36)43(65)32(18-11-12-21-46)54-41(63)35(52-29(6)58)25-30-16-9-8-10-17-30/h8-10,16-17,26-28,31-36H,7,11-15,18-25,46H2,1-6H3,(H,50,61)(H,51,62)(H,52,58)(H,53,59)(H,54,63)(H,55,60)(H,56,64)(H,66,67)(H4,47,48,49)/t27-,28-,31-,32-,33-,34-,35-,36-/m0/s1
Standard InChI Key: YWNMAFCGUIGVDU-HZMLVDQPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 943.16 | Molecular Weight (Monoisotopic): 942.5651 | AlogP: -1.00 | #Rotatable Bonds: 29 |
Polar Surface Area: 349.23 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.55 | CX LogP: -3.19 | CX LogD: -5.66 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: -0.01 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):